Association between duration of use of pharmacotherapy and smoking cessation: Findings from a national survey

BMJ Open

Volumn 5, Issue 1, 2015, Pages

  Siahpush, Mohammad ^a   Shaikh, Raees A ^a   McCarthy, Molly ^a   Sikora Kessler, Asia ^a   Tibbits, Melissa ^a   Singh, Gopal K ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE LOZENGE; NICOTINE PATCH; NOSE SPRAY; VARENICLINE; NICOTINE GUM; NICOTINIC AGENT;

ADULT; ARTICLE; COUNSELING; FEMALE; HEALTH CARE SURVEY; HUMAN; INTERNAL VALIDITY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PRESCRIPTION; SMOKING CESSATION; TOBACCO DEPENDENCE; TOBACCO USE; TREATMENT DURATION; AGED; HEALTH SURVEY; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; SMOKING; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER; UNITED STATES; UTILIZATION;

ADULT; AGED; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; UNITED STATES;

EID: 84921929485     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006229     Document Type: Article

References (36)

1. Raupach T, van Schayck CP. Pharmacotherapy for smoking cessation: current advances and research topics. CNS Drugs 2011;25:371-82.
2. Cahill K, Stevens S, Lancaster T. Pharmacological treatments for smoking cessation. JAMA 2014;311:193-4.
3. Kasza KA, Hyland AJ, Borland R, et al. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction 2013;108:193-202.
4. West R, Zhou X. Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax 2007;62:998-1002.
5. Cummings KM, Fix B, Celestino P, et al. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract 2006;12:37-43.
6. Miller N, Frieden TR, Liu SY, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 2005;365:1849-54.
7. Shiffman S, Brockwell SE, Pillitteri JL, et al. Use of smoking-cessation treatments in the United States. Am J Prev Med 2008;34:102-11.
8. Alberg AJ, Patnaik JL, May JW, et al. Nicotine replacement therapy use among a cohort of smokers. J Addict Dis 2005;24:101-13.
9. Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health 2007;97:1503-9.
10. Hagimoto A, Nakamura M, Morita T, et al. Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1 year follow-up study. Addiction 2010;105:164-73.
11. Yang J, Hammond D, Driezen P, et al. The use of cessation assistance among smokers from China: findings from the ITC China Survey. BMC Public Health 2011;11:75.
12. Alpert HR, Connolly GN, Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control 2013;22:32-7.
13. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002;288:1260-4.
14. Hughes JR, Peters EN, Naud S. Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials. Nicotine Tob Res 2011;13:512-22.
15. Walsh RA. Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness. Drug Alcohol Rev 2008;27:529-47.
16. Kotz D, West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control 2009;18:43-6.
17. Borland R, Partos TR, Cummings KM. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res 2012;14:1483-7.
18. Shiffman S, Di Marino ME, Sweeney CT. Characteristics of selectors of nicotine replacement therapy. Tob Control 2005;14:346-55.
19. Kotz D, Brown J, West R. 'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction 2014;109:491-9.
20. Raupach T, Brown J, Herbec A, et al. A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction 2014;109:35-43.
21. Shiffman S, Sweeney CT, Ferguson SG, et al. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10 week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clin Ther 2008;30:1852-8.
22. Lee JH, Jones PG, Bybee K, et al. A longer course of varenicline therapy improves smoking cessation rates. Prev Cardiol 2008;11:210-14.
23. US Department of Commerce, Census Bureau. National Cancer Institute and Centers for Disease Control and Prevention Co-sponsored Tobacco Use Supplement to the Current Population Survey (2010-2011). 2012. http://riskfactor.cancer.gov/studies/tus?cps/(accessed 21 June 2014).
24. US Census Bureau. Current population survey: design and methodology. Technical Paper TP63RV. Washington DC: Bureau of Labor Statistics and US Census Bureau, October 2006;2014 (Februrary 10).
25. Gould W. Jackknife estimation. Stata Tech Bull 1995;24:25-29.
26. The US Census Bureau. Current Population Survey: imputation of unreported data items. 2014;2014(03/18).
27. Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J 2012;12:308.
28. Raupach T, Shahab L, Neubert K, et al. Implementing a hospital-based smoking cessation programme: evidence for a learning effect. Patient Educ Couns 2008;70:199-204.
29. Fu SS, Burgess D, van Ryn M, et al. Views on smoking cessation methods in ethnic minority communities: a qualitative investigation. Prev Med 2007;44:235-40.
30. Ryan KK, Garrett-Mayer E, Alberg AJ, et al. Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res 2011;13:646-52.
31. Cokkinides VE, Ward E, Jemal A, et al. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med 2005;28:119-22.
32. Shiffman S. Use of more nicotine lozenges leads to better success in quitting smoking. Addiction 2007;102:809-14.
33. Pfizer Inc. Getting started with CHANTIX: Things to Remember. 2014. https://www.chantix.com/things-to-remember.aspx (accessed 3 June 2014).
34. Caponnetto P, Polosa R. Common predictors of smoking cessation in clinical practice. Respir Med 2008;102:1182-92.
35. Siahpush M, Carlin JB. Financial stress, smoking cessation and relapse: results from a prospective study of an Australian national sample. Addiction 2006;110:121-7.
36. Berg CJ, An LC, Kirch M, et al. Failure to report attempts to quit smoking. Addict Behav 2010;35:900-4.